CUMBERLAND PHARMACEUTICALS INC (CPIX) › Cash & EquivalentsCUMBERLAND PHARMACEUTICALS INC (CPIX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $11.83M2009: $78.70M2010: $65.89M2011: $70.60M2012: $54.35M2013: $40.87M2014: $39.87M2015: $38.20M2016: $34.51M2017: $45.41M2018: $27.94M2019: $28.21M2020: $24.75M2021: $27.04M2022: $19.76M2023: $18.32M2024: $17.96M2025: $11.44M$11.44M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$11.44M-36.3%2024$17.96M-2.0%2023$18.32M-7.3%2022$19.76M-26.9%2021$27.04M+9.2%2020$24.75M-12.3%2019$28.21M+1.0%2018$27.94M-38.5%2017$45.41M+31.6%2016$34.51M-9.7%2015$38.20M-4.2%2014$39.87M-2.5%2013$40.87M-24.8%2012$54.35M-23.0%2011$70.60M+7.1%2010$65.89M-16.3%2009$78.70M+565.3%2008$11.83M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share